{
    "pmcid": "7199733",
    "qa_pairs": {
        "What enhancement was made to the VHHs to improve their neutralization potency against SARS-CoV-2?": [
            "Engineering into bivalent formats",
            "Addition of a fluorescent tag",
            "Conjugation with gold nanoparticles",
            "Fusion with a bacterial toxin"
        ],
        "What structural feature of the VHHs contributes to their mechanism of neutralization?": [
            "Occlusion of the receptor-binding interface",
            "Binding to the viral nucleocapsid",
            "Interaction with viral RNA",
            "Cleavage of the viral envelope"
        ],
        "What was the expression system used for producing the selected VHHs?": [
            "Pichia pastoris",
            "Escherichia coli",
            "Baculovirus-insect cell system",
            "Mammalian cell culture"
        ],
        "What was the primary method used to generate the VHH library in the study?": [
            "Phage display technology",
            "CRISPR-Cas9 gene editing",
            "Hybridoma technology",
            "Yeast two-hybrid screening"
        ],
        "Which specific viral proteins were the nanobodies targeting in the study?": [
            "Spike (S) proteins of MERS-CoV and SARS-CoV-1",
            "Nucleocapsid proteins of SARS-CoV-2",
            "Envelope proteins of MERS-CoV",
            "Membrane proteins of SARS-CoV-1"
        ]
    }
}